ETHANOL LEAF EXTRACT OF FICUS EXASPERATA ATTENUATES CHANGES IN ELECTROLYTES AND LIPID PROFILES IN A RAT MODEL OF OLANZAPINE-INDUCED OBESITY

Authors

  • Olufunke Onaadepo
    University of Abuja image/svg+xml
  • Roqeeb Busayo Babawale
    Department of Physiology, University of Ilesa, Ilesa, Osun state, Nigeria.
  • Ejike Daniel Eze
    Department of Physiology, School of Medicine, Kabale University, Kabale, Uganda
  • Nachamada Solomon Emmanuel
    Department of Human Physiology, Faculty of Basic Medical Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria. Kaduna State, Nigeria

Keywords:

Ficus exasperata, Electrolytes, Lipid profiles, Olanzapine-induced obesity, Ethanol leaf extract

Abstract

Obesity is a major public health concern characterized by excessive body fat, which increases the risk of numerous health conditions, including heart disease, diabetes, high blood pressure, and certain cancers. Addressing obesity is crucial for improving overall health and well-being. In this study, thirty female Wistar rats, weighing between 190 and 200 g, were utilized to investigate the effects of Ficus exasperata on olanzapine-induced obesity.  After a two-week acclimatization period, obesity was induced in the designated group using olanzapine (4 mg/kg) via oral gavage for 28 days. The rats were then divided into five groups (n = 6): normal control, obese-untreated, non-obese treated with Ficus exasperata (100 mg/kg), obese treated with Ficus exasperata (100 mg/kg), and obese treated with orlistat (100 mg/kg). Treatments were administered orally for 28 days. At the end of the study, the animals were sacrificed, and blood samples were collected for serum analysis. The study demonstrated that Ficus exasperata significantly (P< 0.05) increases bicarbonate and potassium while reducing sodium and calcium (P< 0.05). Ficus exasperata significantly (P< 0.05) reduces HDL with a significant (P< 0.05) increase in TC, TG and LDL. These findings suggest that Ficus exasperata influences both electrolyte balance and lipid metabolism in obese animals.

Author Biography

Olufunke Onaadepo

Department of Human Physiology, Faculty of Basic Medical Sciences, University of Abuja. Nigeria

Dimensions

Abotsi, W. M., Woode, E., Ainooson, G. K., Amo-Barimah, A. K., & Boakye-Gyasi, E. (2010). Antiarthritic and antioxidant effects of the leaf extract of Ficus exasperata P. Beauv. (Moraceae). Pharmacognosy Research, 2(2), 8997. https://doi.org/10.4103/0974-8490.62958

Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Annett, S., Boison, D., Burns, K. E., Dessauer, C., Gertsch, J., Helsby, N. A., Izzo, A. A., Ostrom, R., Papapetropoulos, A., ... Wong, S. S. (2023). The concise guide to PHARMACOLOGY 2023/24: Enzymes. British Journal of Pharmacology, 180(S2). https://doi.org/10.1111/bph.16181

Alptekin, . M., akrolu, F. P., Reber, T., & Nemutlu, E. (2024). Inulin may prevent the high-fat diet induced-obesity via suppressing endocannabinoid system in the prefrontal cortex in Wistar rats. International Journal of Food Sciences and Nutrition, 75(8), 800811. https://doi.org/10.1080/09637486.2024.2408545

Awoyemi, T., Guzman, R. B., & Naveed, A. (2024). Olanzapineinduced cardiomyopathy: A mimicker of obesity cardiomyopathy? Clinical Cardiology, 47(5), e24278.

Balbo, M. S., Hallak, J. E. C., Nunes, E. A., Triffoni-Melo, T., Ferreira, S., Chaves, C., Duro, A. M. S., Ramos, A. P. P., Crippa, S., & Costa Queiroz, R. H. (2014). Olanzapine, weight change and metabolic effects: A naturalistic 12-month follow-up. Therapeutic Advances in Psychopharmacology, 4(1), 30. https://doi.org/10.1177/2045125313507738

Bingol, Z., Phtl, A., Cagatay, P., Okumus, G., & Kyan, E. (2015). Clinical predictors of obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea. Respiratory Care, 60(5), 666672. https://doi.org/10.4187/respcare.03733

Bruijn, N., Van Lohuizen, R., Boron, M., Fitzek, M., Gabriele, F., Giuliani, G., Melgarejo, L., ehulka, P., Sebastianelli, G., Triller, P., Vigneri, S., zcan, B., & Van Den Brink, A. M. (2024). Influence of metabolic state and body composition on the action of pharmacological treatment of migraine. The Journal of Headache and Pain, 25(1). https://doi.org/10.1186/s10194-024-01724-3

Chang, C., Goh, K. K., & Lu, L. (2021). Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World Journal of Psychiatry, 11(10), 696. https://doi.org/10.5498/wjp.v11.i10.696

Chen, C., Nakano, T., Hsu, W., Chu, C. Y., & Huang, T. (2022). Early lipid metabolic effects of the anti-psychotic drug olanzapine on weight gain and associated gene expression. Neuropsychiatric Disease and Treatment, 18, 645. https://doi.org/10.2147/NDT.S345046

Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177

Ellis, L. R., Zulfiqar, S., Holmes, M., Marshall, L., Dye, L., & Boesch, C. (2022). A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutrition Reviews, 80(6), 1723. https://doi.org/10.1093/nutrit/nuab104

Ellulu, M. S., Patimah, I., Khaza'ai, H., Rahmat, A., & Abed, Y. (2017). Obesity and inflammation: The linking mechanism and the complications. Archives of Medical Science, 13(4), 851863. https://doi.org/10.5114/aoms.2016.58928

George, T. T., Oyenihi, A. B., Oyenihi, O. R., & Obilana, A. O. (2023). Composition and health-promoting effects of fig (Ficus carica) extracts. In Fig (Ficus carica): Production, processing, and properties (pp. 561578). Springer. https://doi.org/10.1007/978-3-031-16493-4_25

Ghai, R., Chaudhary, S., Nagarajan, K., Goel, R., et al. (2023). An investigative study of medicinal herbs for anti-obesity potential. Oriental Journal of Chemistry, 39. https://doi.org/10.13005/ojc/390605

Hamm, L. L., Nakhoul, N., & Hering-Smith, K. S. (2015). Acid-base homeostasis. Clinical Journal of the American Society of Nephrology, 10(12), 22322242. https://doi.org/10.2215/CJN.07400715

Harahap, I. A., Landrier, J. F., & Suliburska, J. (2022). Interrelationship between Vitamin D and Calcium in obesity and its comorbid conditions. Nutrients, 14(15), 3187. https://doi.org/10.3390/nu14153187

Hasan, B., Nayfeh, T., Alzuabi, M., Wang, Z., Kuchkuntla, A. R., Prokop, L. J., Newman, C. B., Murad, M. H., & Rajjo, T. I. (2020). Weight loss and serum lipids in overweight and obese adults: A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 105(12), dgaa673. https://doi.org/10.1210/clinem/dgaa673

Hasnat, H., Alam, S., Shompa, S. A., et al. (2024). Phyto-pharmacological wonders of genus Ficus: Ethnopharmacological insights and phytochemical treasures from natural products. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102211

Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2021). Recent molecular mechanisms and beneficial effects of phytochemicals and plant-based whole foods in reducing LDL-C and preventing cardiovascular disease. Antioxidants (Basel), 10(5), 784. https://doi.org/10.3390/antiox10050784

Kofie, W., Osman, H., & Bekoe, S. O. (2015). Phytochemical properties of extracts and isolated fractions of leaves and stem bark of Ficus exasperata. World Journal of Pharmacy and Pharmaceutical Sciences, 4.

Kolb, H., Kempf, K., & Rhling, M. (2021). Ketone bodies: From enemy to friend and guardian angel. BMC Medicine, 19, 313. https://doi.org/10.1186/s12916-021-02185-0

Kuhn, C., Mohebbi, N., & Ritter, A. (2024). Metabolic acidosis in chronic kidney disease: Mere consequence or also culprit? Pflgers Archiv - European Journal of Physiology, 476, 579592. https://doi.org/10.1007/s00424-024-02912-5

Laguado, S. A., & Saklad, S. R. (2022). Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review. Mental Health Clinician, 12(4), 254262. https://doi.org/10.9740/mhc.2022.08.254

Lian, J., Huang, F., Pai, N., & Deng, C. (2014). Preventing olanzapine-induced weight gain using betahistine: A study in a rat model with chronic olanzapine treatment. PLOS ONE, 9(8), e104160. https://doi.org/10.1371/journal.pone.0104160

Lingvay, I., Cohen, R. V., le Roux, C. W., & Sumithran, P. (2024). Obesity in adults. The Lancet, 404(10456), 972987.

Lund, B. C., & Perry, P. J. (2000). Olanzapine: An atypical antipsychotic for schizophrenia. Expert Opinion on Pharmacotherapy, 1(2), 305323. https://doi.org/10.1517/14656566.1.2.305

Mahboob, A., Samuel, S. M., Mohamed, A., Wani, M. Y., et al. (2023). Role of flavonoids in controlling obesity: Molecular targets and mechanisms. Frontiers in Nutrition, 10, 1177897. https://doi.org/10.3389/fnut.2023.1177897

Mathus-Vliegen, L., Toouli, J., Fried, M., Khan, A. G., Garisch, J., Hunt, R., Fedail, S., timac, D., Lemair, T., Krabshuis, J., Kaufmann, P., Roberts, E., & Riccardi, G. (2012). World Gastroenterology Organisation global guidelines on obesity. Journal of Clinical Gastroenterology, 46(7), 555561. https://doi.org/10.1097/mcg.0b013e318259bd04

Musabayane, C. T. (2012). The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovascular Journal of Africa, 23(8), 462468. https://doi.org/10.5830/CVJA-2012-025

Mutiso, S. K., Rono, D. K., & Bukachi, F. (2014). Relationship between anthropometric measures and early electrocardiographic changes in obese rats. BMC Research Notes, 7, 931. https://doi.org/10.1186/1756-0500-7-931

Nagami, G. T., & Kraut, J. A. (2024). The role of the endocrine system in the regulation of acidbase balance by the kidney and the progression of chronic kidney disease. International Journal of Molecular Sciences, 25(4), 2420. https://doi.org/10.3390/ijms25042420

Narasimhan, M., Bruce, T. O., & Masand, P. (2007). Review of olanzapine in the management of bipolar disorders. Neuropsychiatric Disease and Treatment, 3(5), 579. https://pmc.ncbi.nlm.nih.gov/articles/PMC2656294

Nawaz, H., Waheed, R., & Nawaz, M. (2020). Phytochemical composition, antioxidant potential, and medicinal significance of ficus. In IntechOpen eBooks. https://doi.org/10.5772/intechopen.86562

NCD Risk Factor Collaboration (NCD-RisC). (2024). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. The Lancet, 403(10431), 10271050.

Noce, A., Marrone, G., Jones, G. W., Lauro, M. D., Zaitseva, A. P., Ramadori, L., Celotto, R., Mitterhofer, A. P., & Daniele, N. D. (2021). Nutritional approaches for the management of metabolic acidosis in chronic kidney disease. Nutrients, 13(8), 2534. https://doi.org/10.3390/nu13082534

Novelli, E. L. B., Diniz, Y. S., Galhardi, C. M., Ebaid, G. M. X., Rodrigues, H. G., Mani, F., Fernandes, A. A. H., Cicogna, A. C., & Novelli Filho, J. L. V. B. (2007). Anthropometrical parameters and markers of obesity in rats. Laboratory Animals, 41(1), 111119. https://doi.org/10.1258/002367707779399518

Nworu, C. S., Nwuke, H. C., Akah, P. A., Okoye, F. B., & Esimone, C. O. (2013). Extracts of Ficus exasperata leaf inhibit topical and systemic inflammation in rodents and suppress LPS-induced expression of mediators of inflammation in macrophages. Journal of Immunotoxicology, 10(3), 302310. https://doi.org/10.3109/1547691X.2012.732121

Okunogbe, A., Nugent, R., Spencer, G., Powis, J., Ralston, J., & Wilding, J. (2022). Economic impacts of overweight and obesity: Current and future estimates for 161 countries. BMJ Global Health, 7(9), e009773. https://doi.org/10.1136/bmjgh-2022-009773

Park, K. (2023). The role of dietary phytochemicals: Evidence from epidemiological studies. Nutrients, 15(6), 1371. https://doi.org/10.3390/nu15061371

Ruban, A., Glaysher, M. A., Miras, A. D., Goldstone, A. P., Prechtl, C. G., Johnson, N., Li, J., Aldhwayan, M., Aldubaikhi, G., Glover, B., Lord, J., Onyimadu, O., Falaschetti, E., Klimowska-Nassar, N., Ashrafian, H., Byrne, J., & Teare, J. P. (2020). A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: A RCT. Efficacy and Mechanism Evaluation, 7(6), 1130. https://doi.org/10.3310/eme07060

Shapses, S. A., & Sukumar, D. (2012). Bone metabolism in obesity and weight loss. Annual Review of Nutrition, 32, 287309. https://doi.org/10.1146/annurev.nutr.012809.104655

Suburu, J., Gu, Z., Chen, H., Chen, W., Zhang, H., Chen, Y. Q. (2013). Fatty acid metabolism: Implications for diet, genetic variation, and disease. Food Bioscience, 4, 112. https://doi.org/10.1016/j.fbio.2013.07.003

Tobar Leito, S. A., Soares, D. D. S., Carvas Junior, N., Zimmer, R., Ludwig, N. F., & Andrades, M. (2021). Study of anesthetics for euthanasia in rats and mice: A systematic review and meta-analysis on the impact upon biological outcomes (SAFE-RM). Life Sciences, 284, 119916. https://doi.org/10.1016/j.lfs.2021.119916

Umaru, I. J., Samuel, O. S., Kerenhappuch, I. U., Yakub, O. E., et al. (2022). Hypertension and plant extract as a solution. Clinical Cardiovascular Research, 1(1). https://doi.org/10.58489/2836-5917/004

Wjcik, M., & Kozio-Kozakowska, A. (2021). Obesity, sodium homeostasis, and arterial hypertension in children and adolescents. Nutrients, 13(11), 4032. https://doi.org/10.3390/nu13114032

Xie, P., Shao, T., & Long, Y. (2024). Orlistat for the treatment of antipsychotic-induced weight gain: An eight-week multicenter, randomized, placebo-controlled, double-blind trial. Lipids in Health and Disease, 23(225). https://doi.org/10.1186/s12944-024-02214-w

Yang, Y., & Wu, R. (2025). Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain. European Archives of Psychiatry and Clinical Neuroscience, 275, 619627. https://doi.org/10.1007/s00406-025-01965-6

Yang, Y., Xie, P., & Long, Y. (2022). Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments. BMC Psychiatry, 22(210). https://doi.org/10.1186/s12888-022-03853-y

Published

14-07-2025

How to Cite

ETHANOL LEAF EXTRACT OF FICUS EXASPERATA ATTENUATES CHANGES IN ELECTROLYTES AND LIPID PROFILES IN A RAT MODEL OF OLANZAPINE-INDUCED OBESITY. (2025). FUDMA JOURNAL OF SCIENCES, 9(7), 49-55. https://doi.org/10.33003/fjs-2025-0907-3576

Issue

Vol. 9 No. 7 (2025): FUDMA Journal of Sciences - Vol. 9 No. 7

Section

Research Articles
Copyright & Licensing

FUDMA Journal of Sciences

How to Cite

ETHANOL LEAF EXTRACT OF FICUS EXASPERATA ATTENUATES CHANGES IN ELECTROLYTES AND LIPID PROFILES IN A RAT MODEL OF OLANZAPINE-INDUCED OBESITY. (2025). FUDMA JOURNAL OF SCIENCES, 9(7), 49-55. https://doi.org/10.33003/fjs-2025-0907-3576

Most read articles by the same author(s)